» Articles » PMID: 20881889

The Menopause-Specific Quality of Life Questionnaire: Psychometric Evaluation Among Breast Cancer Survivors

Overview
Journal Menopause
Date 2010 Oct 1
PMID 20881889
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to evaluate the psychometric properties of the Menopause-Specific Quality of Life Questionnaire (MENQOL) in a sample of breast cancer survivors experiencing menopausal symptoms.

Methods: This was a secondary analysis of MENQOL psychometric data from two larger parent studies investigating acupuncture for the relief of menopausal symptoms among breast cancer survivors. Reliability was assessed for each subscale of the MENQOL via (1) internal consistency reliability with Cronbach α and (2) test-retest reliability at multiple follow-up points with intraclass correlation coefficients and r. Convergent and discriminant validities were assessed via correlations of the vasomotor and psychosocial MENQOL subscales with select items in the Kupperman index and daily symptom diary. A principal components analysis was performed to determine construct validity.

Results: For each subscale, Cronbach α was 0.70 or greater. All subscale test-retest reliabilities at first follow-up were significant and at least moderately correlated (≥ 0.450; r's and intraclass correlation coefficients). Convergent validity was moderate between the vasomotor and psychosocial subscales and the symptom diary (r ≥ 0.410, P < 0.001) and larger between these domains and the Kupperman index (r ≥ 0.614, P < 0.001). In the same subscales, discriminant validity was supported by low, nonsignificant correlations (r ≤ 0.176, P > 0.05). The principal components analysis revealed a latent structure nearly identical to the prespecified instrument domains, with the exception of the physical domain.

Conclusions: With results comparable with those obtained in previous psychometric work, the MENQOL seems to be a reliable and valid instrument to assess quality of life in postmenopausal breast cancer survivors.

Citing Articles

Olive Leaf Extract Supplementation Improves Postmenopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Parallel Study on Postmenopausal Women.

Imperatrice M, Lasfar A, van Kalkeren C, Troost F Nutrients. 2024; 16(22).

PMID: 39599665 PMC: 11597182. DOI: 10.3390/nu16223879.


Dysmenorrhea and Its Impact on Patients' Quality of Life-A Cross-Sectional Study.

Amza M, Findeklee S, Haj Hamoud B, Sima R, Poenaru M, Popescu M J Clin Med. 2024; 13(19).

PMID: 39407720 PMC: 11477228. DOI: 10.3390/jcm13195660.


Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.

Schultz N, Morga A, Siddiqui E, Rhoten S Adv Ther. 2024; 41(6):2233-2252.

PMID: 38396203 PMC: 11133125. DOI: 10.1007/s12325-024-02787-z.


Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review.

Claes M, Tuts L, Robijns J, Mulders K, Van De Werf E, Bulens P J Cancer Surviv. 2024; .

PMID: 38383907 DOI: 10.1007/s11764-024-01553-y.


Menopausal Status Impact on the Quality of Life in Kazakhstani Healthcare Workers: A Cross-sectional Study.

Terzic S, Bapayeva G, Kadroldinova N, Sarria-Santamera A, Gusmanov A, Semenova Y J Gen Intern Med. 2024; 39(6):969-977.

PMID: 38315409 PMC: 11074092. DOI: 10.1007/s11606-024-08650-9.


References
1.
Knobf M . The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs. 2001; 24(3):201-10; quiz 210-1. View

2.
Fenlon D, Rogers A . The experience of hot flushes after breast cancer. Cancer Nurs. 2007; 30(4):E19-26. DOI: 10.1097/01.NCC.0000281731.95113.a3. View

3.
Canney P, Hatton M . The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol (R Coll Radiol). 1994; 6(5):297-9. DOI: 10.1016/s0936-6555(05)80270-5. View

4.
Carpenter J, Andrykowski M . Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum. 1999; 26(8):1311-7. View

5.
Lower E, Blau R, Gazder P, Tummala R . The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med. 1999; 8(7):949-54. DOI: 10.1089/jwh.1.1999.8.949. View